MedPath

The safety of postoperative care without nasogastric tube after pylorus-resecting pancreaticoduodenectomy

Not Applicable
Conditions
periampullary tumor or inflammatory disease
Registration Number
JPRN-UMIN000040417
Lead Sponsor
Wakayama Medical University
Brief Summary

The rate of nasogastric tube reinsertion was 10.1% (47/465).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
465
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who refused to be enrolled in this trial 2) Patients who are judged inappropriate by investigators

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath